Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Functional imaging of concomitant lingual thyroid and parathyroid adenoma.

Ferriere A, Schwartz P, Haissaguerre M, Hindié E, Tabarin A.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1201-1202. doi: 10.1007/s00259-019-04283-x. Epub 2019 Feb 20. No abstract available.

PMID:
30788533
2.

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T).

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968.

PMID:
30715419
3.

Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.

Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libé R, Ajzenberg C, Bernardeschi D, Cariou B, Chabolle F, Chabre O, Darrouzet V, Delemer B, Desailloud R, Goichot B, Esvant A, Offredo L, Herman P, Laboureau S, Lefebvre H, Pierre P, Raingeard I, Reznik Y, Sadoul JL, Hadoux J, Tabarin A, Tauveron I, Zenaty D, Favier J, Bertherat J, Baudin E, Amar L, Gimenez-Roqueplo AP; French Group of Endocrine Tumors (GTE) and COMETE Network.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1109-1118. doi: 10.1210/jc.2018-02411.

PMID:
30698717
4.

[Update of the recommendations of good clinical practice for the use of PET in oncology].

Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Lucian A, Cachin F.

Bull Cancer. 2019 Mar;106(3):262-274. doi: 10.1016/j.bulcan.2019.01.002. Epub 2019 Jan 23. French.

PMID:
30683308
5.

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.

Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, Else T, Dvorakova S, Qi XP, Elisei R, Maia AL, Glod J, Lourenço DM Jr, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Patocs A, Bugalho MJ, Lacroix A, Caron P, Fainstein-Day P, Borson Chazot F, Klein M, Links TP, Letizia C, Fugazzola L, Chabre O, Canu L, Cohen R, Tabarin A, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Brue T, Mirebeau-Prunier D, Leclerc L, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Barontini M, Vaz Ferreira Vargas C, Valerio L, Ceolin L, Akshintala S, Hoff A, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E.

Lancet Diabetes Endocrinol. 2019 Mar;7(3):213-220. doi: 10.1016/S2213-8587(18)30336-X. Epub 2019 Jan 16. Erratum in: Lancet Diabetes Endocrinol. 2019 Mar;7(3):e3.

PMID:
30660595
6.

Unilateral Adrenalectomy Could Be a Valid Option for Primary Nodular Adrenal Disease: Evidence From Twins.

Kyrilli A, Lytrivi M, Bouquegneau MS, Demetter P, Lucidi V, Garcia C, Moreno-Reyes R, Tabarin A, Corvilain B, Driessens N.

J Endocr Soc. 2018 Oct 24;3(1):129-134. doi: 10.1210/js.2018-00261. eCollection 2019 Jan 1.

7.

Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).

Vinault S, Mariet AS, Le Bras M, Mirallié E, Cardot-Bauters C, Pattou F, Ruszniewski P, Sauvanet A, Chanson P, Baudin E, Elias D, Menegaux F, Gaujoux S, Borson-Chazot F, Lifante JC, Caron P, Carrère N, Tabarin A, Laurent C, Klein M, Brunaud L, Niccoli P, Sebag F, Cadiot G, Kianmanesh R, Luu M, Binquet C, Goudet P.

Ann Surg. 2018 Dec 21. doi: 10.1097/SLA.0000000000003162. [Epub ahead of print]

PMID:
30585820
8.

Diagnosis of mosaic mutations in the MEN1 gene by next generation sequencing.

Coppin L, Ferrière A, Crépin M, Haissaguerre M, Ladsous M, Tabarin A, Odou MF.

Eur J Endocrinol. 2019 Feb 1;180(2):L1-L3. doi: 10.1530/EJE-18-0852. No abstract available.

PMID:
30444722
9.

CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.

Canu L, Van Hemert JAW, Kerstens MN, Hartman RP, Khanna A, Kraljevic I, Kastelan D, Badiu C, Ambroziak U, Tabarin A, Haissaguerre M, Buitenwerf E, Visser A, Mannelli M, Arlt W, Chortis V, Bourdeau I, Gagnon N, Buchy M, Borson-Chazot F, Deutschbein T, Fassnacht M, Hubalewska-Dydejczyk A, Motyka M, Rzepka E, Casey RT, Challis BG, Quinkler M, Vroonen L, Spyroglou A, Beuschlein F, Lamas C, Young WF, Bancos I, Timmers HJLM.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):312-318. doi: 10.1210/jc.2018-01532.

PMID:
30383267
10.

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.

Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P.

Endocrine. 2019 Jan;63(1):130. doi: 10.1007/s12020-018-1789-8.

11.

Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?

Ollivier M, Haissaguerre M, Ferriere A, Tabarin A.

Eur J Endocrinol. 2018 Oct 12;179(5):L1-L2. doi: 10.1530/EJE-18-0694.

PMID:
30320504
12.

Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.

Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P.

Endocrine. 2019 Jan;63(1):120-129. doi: 10.1007/s12020-018-1764-4. Epub 2018 Sep 29. Erratum in: Endocrine. 2018 Oct 31;:.

13.

[Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].

Vermalle M, Tabarin A, Castinetti F.

Ann Endocrinol (Paris). 2018 Sep;79 Suppl 1:S10-S21. doi: 10.1016/S0003-4266(18)31234-4. Review. French.

PMID:
30213301
14.

Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer.

Borson-Chazot F, Dantony E, Illouz F, Lopez J, Niccoli P, Wassermann J, Do Cao C, Leboulleux S, Klein M, Tabarin A, Eberle MC, Benisvy D, de la Fouchardière C, Bournaud C, Lasolle H, Delahaye A, Rabilloud M, Lapras V, Decaussin-Petrucci M, Schlumberger M.

Thyroid. 2018 Sep;28(9):1174-1179. doi: 10.1089/thy.2017.0663.

PMID:
30105951
15.

NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin.

Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D.

Front Pharmacol. 2018 May 15;9:527. doi: 10.3389/fphar.2018.00527. eCollection 2018.

16.

Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score.

Vinolas H, Grouthier V, Mehsen-Cetre N, Boisson A, Winzenrieth R, Schaeverbeke T, Mesguich C, Bordenave L, Tabarin A.

Clin Endocrinol (Oxf). 2018 May 21. doi: 10.1111/cen.13743. [Epub ahead of print]

PMID:
29781519
17.

mTORC1-dependent increase in oxidative metabolism in POMC neurons regulates food intake and action of leptin.

Haissaguerre M, Ferrière A, Simon V, Saucisse N, Dupuy N, André C, Clark S, Guzman-Quevedo O, Tabarin A, Cota D.

Mol Metab. 2018 Jun;12:98-106. doi: 10.1016/j.molmet.2018.04.002. Epub 2018 Apr 13.

18.

Do the diagnostic criteria for subclinical hypercortisolism exist?

Tabarin A.

Ann Endocrinol (Paris). 2018 Jun;79(3):146-148. doi: 10.1016/j.ando.2018.03.013. Epub 2018 Apr 13. Review.

PMID:
29661471
19.

Serum GH concentration must now be expressed in mass units in France like in the rest of the world.

Chanson P, Reynaud R, Coutant R, Linglart A, Nicolino M, Rodien P, Borson-Chazot F, Tabarin A, Le Bouc Y, Piketty ML, Gauchez AS, Chevenne D, Porquet D, Souberbielle JC.

Ann Biol Clin (Paris). 2018 Apr 1;76(2):133-134. doi: 10.1684/abc.2018.1322. No abstract available.

PMID:
29623880
20.

Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.

Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Tóth M, Webb SM, Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price J, Wass JA, Papakokkinou E, Ragnarsson O; ERCUSYN Study Group.

Clin Endocrinol (Oxf). 2018 Jun;88(6):787-798. doi: 10.1111/cen.13600. Epub 2018 Apr 16. Erratum in: Clin Endocrinol (Oxf). 2018 Nov;89(5):678.

PMID:
29574994
21.

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).

Rault-Petit B, Do Cao C, Guyétant S, Guimbaud R, Rohmer V, Julié C, Baudin E, Goichot B, Coriat R, Tabarin A, Ramos J, Goudet P, Hervieu V, Scoazec JY, Walter T.

Ann Surg. 2019 Jul;270(1):165-171. doi: 10.1097/SLA.0000000000002736.

PMID:
29557879
22.

Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population.

Marty M, Gaye D, Perez P, Auder C, Nunes ML, Ferriere A, Haissaguerre M, Tabarin A.

Eur J Endocrinol. 2018 May;178(5):439-446. doi: 10.1530/EJE-17-1056. Epub 2018 Feb 21.

PMID:
29467231
23.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Krsek M, Fajardo C, Bolanowski M, Santos A, Trainer PJ, Wass JAH, Tabarin A; ERCUSYN Study Group.

Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.

24.

SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.

Reznik Y, Barat P, Bertherat J, Bouvattier C, Castinetti F, Chabre O, Chanson P, Cortet C, Delemer B, Goichot B, Gruson D, Guignat L, Proust-Lemoine E, Sanson MR, Reynaud R, Boustani DS, Simon D, Tabarin A, Zenaty D.

Ann Endocrinol (Paris). 2018 Feb;79(1):1-22. doi: 10.1016/j.ando.2017.12.001. Epub 2018 Jan 12.

25.

Serum GH concentrations must now be expressed in mass units in France…as in the rest of the world.

Chanson P, Reynaud R, Coutant R, Linglart A, Nicolino M, Rodien P, Borson-Chazot F, Tabarin A, Le Bouc Y, Piketty ML, Gauchez AS, Chevenne D, Porquet D, Souberbielle JC.

Ann Endocrinol (Paris). 2017 Dec;78(6):488-489. doi: 10.1016/j.ando.2017.11.002. No abstract available.

PMID:
29229062
26.

Group 3: Strategies for identifying the cause of adrenal insufficiency: diagnostic algorithms.

Proust-Lemoine E, Reynaud R, Delemer B, Tabarin A, Samara-Boustani D.

Ann Endocrinol (Paris). 2017 Dec;78(6):512-524. doi: 10.1016/j.ando.2017.10.006. Epub 2017 Nov 24. Review. No abstract available.

PMID:
29174932
27.

Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis.

Chanson P, Guignat L, Goichot B, Chabre O, Boustani DS, Reynaud R, Simon D, Tabarin A, Gruson D, Reznik Y, Raffin Sanson ML.

Ann Endocrinol (Paris). 2017 Dec;78(6):495-511. doi: 10.1016/j.ando.2017.10.005. Epub 2017 Nov 23. Review.

PMID:
29174200
28.

La chirurgie d’épargne surrénalienne : du cortex à la médulla: Cortical sparing surgery: from cortex to medulla.

Ferriere A, Kerlan V, Tabarin A.

Ann Endocrinol (Paris). 2017 Oct;78 Suppl 1:S11-S20. doi: 10.1016/S0003-4266(17)30921-6. Review. French.

PMID:
29157485
29.

Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

Vezzosi D, Do Cao C, Hescot S, Bertherat J, Haissaguerre M, Bongard V, Drui D, De La Fouchardière C, Illouz F, Borson-Chazot F, Djobo B, Berdelou A, Tabarin A, Schlumberger M, Briet C, Caron P, Leboulleux S, Libe R, Baudin E; For Comete-Cancer Network.

Horm Cancer. 2018 Feb;9(1):62-69. doi: 10.1007/s12672-017-0313-6. Epub 2017 Oct 25.

PMID:
29071575
30.

Advantages and Limits of Targeted Radionuclide Therapy with Somatostatin Antagonists.

Hindié E, Morgat C, Zanotti-Fregonara P, Haissaguerre M, Bordenave L, Tabarin A.

J Nucl Med. 2018 Mar;59(3):546-547. doi: 10.2967/jnumed.117.202630. Epub 2017 Oct 6. No abstract available.

31.

Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Lecoq AL, Stratakis CA, Viengchareun S, Chaligné R, Tosca L, Deméocq V, Hage M, Berthon A, Faucz FR, Hanna P, Boyer HG, Servant N, Salenave S, Tachdjian G, Adam C, Benhamo V, Clauser E, Guiochon-Mantel A, Young J, Lombès M, Bourdeau I, Maiter D, Tabarin A, Bertherat J, Lefebvre H, de Herder W, Louiset E, Lacroix A, Chanson P, Bouligand J, Kamenický P.

JCI Insight. 2017 Sep 21;2(18). pii: 92184. doi: 10.1172/jci.insight.92184. eCollection 2017 Sep 21.

32.

Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.

Lecomte P, Binquet C, Le Bras M, Tabarin A, Cardot-Bauters C, Borson-Chazot F, Lombard-Bohas C, Baudin E, Delemer B, Klein M, Vergès B, Aparicio T, Cosson E, Beckers A, Caron P, Chabre O, Chanson P, Du Boullay H, Guilhem I, Niccoli P, Rohmer V, Guigay J, Vulpoi C, Scoazec JY, Goudet P.

World J Surg. 2018 Jan;42(1):143-152. doi: 10.1007/s00268-017-4135-z.

PMID:
28785839
33.

Diagnosis and Differential Diagnosis of Cushing's Syndrome.

Findling JW, Nieman L, Tabarin A.

N Engl J Med. 2017 Jul 13;377(2):e3. doi: 10.1056/NEJMc1705984. No abstract available.

PMID:
28704025
34.

[Hypercalcemia and inactive mutation of CYP24A1. Case-study and literature review].

Seidowsky A, Villain C, Vilaine E, Baudoin R, Tabarin A, Kottler ML, Cavalier É, Souberbielle JC, Massy ZA.

Nephrol Ther. 2017 May;13(3):146-153. doi: 10.1016/j.nephro.2017.01.019. Epub 2017 May 3. Review. French.

PMID:
28456639
35.

Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.

Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer C, Hindié E, Loundou A, Archange C, Tabarin A, Sebag F, Baumstarck K, Taïeb D.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2465-2472. doi: 10.1210/jc.2017-00254.

PMID:
28431167
36.

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JAH, Trainer PJ; ERCUSYN Study Group.

Eur J Endocrinol. 2017 May;176(5):613-624. doi: 10.1530/EJE-16-0967.

PMID:
28377460
37.

Cabergoline for Cushing's disease: a large retrospective multicenter study.

Ferriere A, Cortet C, Chanson P, Delemer B, Caron P, Chabre O, Reznik Y, Bertherat J, Rohmer V, Briet C, Raingeard I, Castinetti F, Beckers A, Vroonen L, Maiter D, Cephise-Velayoudom FL, Nunes ML, Haissaguerre M, Tabarin A.

Eur J Endocrinol. 2017 Mar;176(3):305-314. doi: 10.1530/EJE-16-0662. Epub 2016 Dec 22.

PMID:
28007845
38.

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

Jouinot A, Assie G, Libe R, Fassnacht M, Papathomas T, Barreau O, de la Villeon B, Faillot S, Hamzaoui N, Neou M, Perlemoine K, Rene-Corail F, Rodriguez S, Sibony M, Tissier F, Dousset B, Sbiera S, Ronchi C, Kroiss M, Korpershoek E, de Krijger R, Waldmann J, K D, Bartsch, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Sturm N, Luconi M, Mantero F, Mannelli M, Cohen R, Kerlan V, Touraine P, Barrande G, Groussin L, Bertagna X, Baudin E, Amar L, Beuschlein F, Clauser E, Coste J, Bertherat J.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):923-932. doi: 10.1210/jc.2016-3205.

PMID:
27967600
39.

Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.

Burnichon N, Mazzella JM, Drui D, Amar L, Bertherat J, Coupier I, Delemer B, Guilhem I, Herman P, Kerlan V, Tabarin A, Wion N, Lahlou-Laforet K, Favier J, Gimenez-Roqueplo AP.

J Med Genet. 2017 Feb;54(2):125-133. doi: 10.1136/jmedgenet-2016-104297. Epub 2016 Nov 17.

PMID:
27856506
40.

Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM.

Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467.

41.

Exercise and the Hypothalamo-Pituitary-Adrenal Axis.

Duclos M, Tabarin A.

Front Horm Res. 2016;47:12-26. doi: 10.1159/000445149. Epub 2016 Jun 27. Review.

PMID:
27348531
42.

SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.

Reznik Y, Amar L, Tabarin A.

Ann Endocrinol (Paris). 2016 Jul;77(3):202-7. doi: 10.1016/j.ando.2016.01.007. Epub 2016 Jun 16.

PMID:
27318644
43.

SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.

Amar L, Baguet JP, Bardet S, Chaffanjon P, Chamontin B, Douillard C, Durieux P, Girerd X, Gosse P, Hernigou A, Herpin D, Houillier P, Jeunemaitre X, Joffre F, Kraimps JL, Lefebvre H, Ménégaux F, Mounier-Véhier C, Nussberger J, Pagny JY, Pechère A, Plouin PF, Reznik Y, Steichen O, Tabarin A, Zennaro MC, Zinzindohoue F, Chabre O.

Ann Endocrinol (Paris). 2016 Jul;77(3):179-86. doi: 10.1016/j.ando.2016.05.001. Epub 2016 Jun 15.

PMID:
27315757
44.

Etiopathogeny of Primary Adrenal Hypercortisolism.

Vélayoudom-Céphise FL, Haissaguerre M, Tabarin A.

Front Horm Res. 2016;46:39-53. doi: 10.1159/000443863. Epub 2016 May 17. Review.

PMID:
27212135
45.

Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.

Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1258-66. doi: 10.1007/s00259-016-3319-3. Epub 2016 Jan 28.

PMID:
26819103
46.

The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice.

Bermudez-Silva FJ, Romero-Zerbo SY, Haissaguerre M, Ruz-Maldonado I, Lhamyani S, El Bekay R, Tabarin A, Marsicano G, Cota D.

Dis Model Mech. 2016 Jan;9(1):51-61. doi: 10.1242/dmm.020750. Epub 2015 Nov 12.

47.

Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.

Debillon E, Velayoudom-Cephise FL, Salenave S, Caron P, Chaffanjon P, Wagner T, Massoutier M, Lambert B, Benoit M, Young J, Tabarin A, Chabre O.

J Clin Endocrinol Metab. 2015 Dec;100(12):4417-24. doi: 10.1210/jc.2015-2662. Epub 2015 Oct 9.

PMID:
26451908
48.

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Le Bras M, Giraud S, Niccoli P, Odou MF, Borson-Chazot F, Barlier A, Lombard-Bohas C, Clauser E, Tabarin A, Pasmant E, Chabre O, Castermans E, Ruszniewski P, Bertherat J, Delemer B, Christin-Maitre S, Beckers A, Guilhem I, Rohmer V, Goichot B, Caron P, Baudin E, Chanson P, Groussin L, Du Boullay H, Weryha G, Lecomte P, Schillo F, Bihan H, Archambeaud F, Kerlan V, Bourcigaux N, Kuhn JM, Vergès B, Rodier M, Renard M, Sadoul JL, Binquet C, Goudet P.

Eur J Endocrinol. 2015 Dec;173(6):819-26. doi: 10.1530/EJE-15-0691. Epub 2015 Sep 21.

PMID:
26392472
49.

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network.

Ann Oncol. 2015 Oct;26(10):2119-25. doi: 10.1093/annonc/mdv329.

50.

Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).

Vezzosi D, Tenenbaum F, Cazabat L, Tissier F, Bienvenu M, Carrasco CA, Laloi-Michelin M, Barrande G, Lefebvre H, Hiéronimus S, Tabarin A, Bertagna X, Legmann P, Vantyghem MC, Bertherat J.

J Clin Endocrinol Metab. 2015 Nov;100(11):4332-8. doi: 10.1210/jc.2015-2174. Epub 2015 Sep 21.

PMID:
26390100

Supplemental Content

Loading ...
Support Center